Skip to main content
. 2023 May 31;2023(5):CD014513. doi: 10.1002/14651858.CD014513
  Predicted proportion of patients screened given different baseline control proportions
QI strategy OR (95% CrI)a in patients who received QI strategyb Order 30% baseline screening (95% CrI) 50% baseline screening (95% CrI) 70% baseline screening (95% CrI)
CM 1.09 (0.59 to 1.83) Bottom 0.32 (0.20 to 0.44) 0.52 (0.37 to 0.65) 0.72 (0.58 to 0.81)
TC 2.01 (0.92 to 4.01) Top 0.46 (0.28 to 0.63) 0.67 (0.48 to 0.80) 0.82 (0.68 to 0.90)
EPR 0.95 (0.35 to 2.42) Bottom 0.29 (0.13 to 0.51) 0.49 (0.26 to 0.71) 0.69 (0.45 to 0.85)
CE 1.03 (0.75 to 1.47) Bottom 0.31 (0.24 to 0.39) 0.51 (0.43 to 0.59) 0.71 (0.64 to 0.77)
CR 1.30 (0.71 to 2.57) Middle 0.36 (0.23 to 0.52) 0.56 (0.41 to 0.72) 0.75 (0.62 to 0.86)
FR 0.85 (0.35 to 2.16) Bottom 0.27 (0.13 to 0.48) 0.46 (0.26 to 0.68) 0.66 (0.45 to 0.83)
PE 2.32 (1.09 to 5.13) Top 0.50 (0.32 to 0.69) 0.70 (0.52 to 0.84) 0.84 (0.72 to 0.92)
PSM  1.28 (0.47 to 3.42) Middle 0.35 (0.17 to 0.59) 0.56 (0.32 to 0.77) 0.75 (0.52 to 0.89)
PR 1.39 (0.46 to 3.70) Middle 0.37 (0.16 to 0.61) 0.58 (0.31 to 0.79) 0.76 (0.52 to 0.90)
Other 1.55 (1.04 to 2.06) Top 0.40 (0.31 to 0.47) 0.61 (0.51 to 0.67) 0.78 (0.71 to 0.83)